Articles

Sort by
Previous Page Page 1 of 10 Next Page
  1. Research

    Competency in supportive supervision: a study of public sector medicines management supervisors in Uganda

    Supportive supervision has been found to be more effective than corrective fault-oriented inspections. Uganda’s Ministry of Health in 2012 implemented a comprehensive strategy (SPARS) to build medicines manage...

    Rachael Henry, Lynda Nantongo, Anita Katharina Wagner, Martha Embrey and Birna Trap

    Journal of Pharmaceutical Policy and Practice 2017 10:33

    Published on: 11 October 2017

  2. Review

    Evaluating the impact of Brexit on the pharmaceutical industry

    The UK Pharmaceutical Industry is arguably one of the most important industries to consider in the negotiations following the Brexit vote. Providing tens of thousands of jobs and billions in tax revenue and re...

    Fawz Kazzazi, Cleo Pollard, Paul Tern, Alejandro Ayuso-Garcia, Jack Gillespie and Inesa Thomsen

    Journal of Pharmaceutical Policy and Practice 2017 10:32

    Published on: 4 October 2017

  3. Research

    Branded prescription drug spending: a framework to evaluate policy options

    High drug spending is a concern for policy makers due to limits on access for patients. Numerous policies have been proposed to address high drug spending. The existence of multifarious proposals makes it diff...

    Jeromie Ballreich, G. Caleb Alexander, Mariana Socal, Taruja Karmarkar and Gerard Anderson

    Journal of Pharmaceutical Policy and Practice 2017 10:31

    Published on: 2 October 2017

  4. Research

    Does access to credit services influence availability of essential child medicines and licensing status among private medicine retail outlets in Uganda?

    Despite making great progress in reducing under five mortality in the last three decades. Uganda still ranks high among countries with the highest under five mortality rates. More than a third (36%) of these d...

    Lorraine Nabbanja Kabunga and Paschal Mujasi

    Journal of Pharmaceutical Policy and Practice 2017 10:30

    Published on: 21 September 2017

  5. Research

    Controlled Substance Agreements for Opioids in a Primary Care Practice

    Opioids are widely prescribed for chronic non cancer pain (CNCP). Controlled substance agreements (CSAs) are intended to increase adherence and mitigate risk with opioid prescribing. We evaluated the demograp...

    Lindsey M. Philpot, Priya Ramar, Muhamad Y. Elrashidi, Raphael Mwangi, Frederick North and Jon O. Ebbert

    Journal of Pharmaceutical Policy and Practice 2017 10:29

    Published on: 12 September 2017

  6. Research

    Hypnotics use in children 0–18 months: moderate agreement between mother-reported survey data and prescription registry data

    Different methods in pharmacoepidemiology can be used to study hypnotic use in children. But neither questionnaire-based data nor prescription records can be considered a “gold standard”. This study aimed to i...

    Ingvild Holdø, Jørgen G. Bramness, Marte Handal, Leila Torgersen, Ted Reichborn-Kjennerud, Eivind Ystrøm, Hedvig Nordeng and Svetlana Skurtveit

    Journal of Pharmaceutical Policy and Practice 2017 10:28

    Published on: 8 September 2017

  7. Letter to the Editor

    Antimicrobial resistance in India

    Isha Patel, Rabia Hussain, Anam Khan, Akram Ahmad, Muhammad Umair Khan and Mohamed Azmi Ahmed Hassalai

    Journal of Pharmaceutical Policy and Practice 2017 10:27

    Published on: 5 September 2017

  8. Research

    Evaluation of a guided continuous quality improvement program in community pharmacies

    The importance of creating and sustaining a strong culture of patient safety has been recognized as a critical component of safe medication use. This study aims to assess changes in attitudes toward patient sa...

    Chanadda Chinthammit, Michael T. Rupp, Edward P. Armstrong, Tara Modisett, Rebecca P. Snead and Terri L. Warholak

    Journal of Pharmaceutical Policy and Practice 2017 10:26

    Published on: 5 September 2017

  9. Research

    Evaluating insulin information provided on discharge summaries in a secondary care hospital in the United Kingdom

    Prescribing errors at the time of hospital discharge are common and could potentially lead to avoidable patient harm, especially when they involve insulin, a high-risk medicine widely used for the treatment of...

    Amie Bain, Lois Nettleship, Sallianne Kavanagh and Zaheer-Ud-Din Babar

    Journal of Pharmaceutical Policy and Practice 2017 10:25

    Published on: 22 August 2017

  10. Research

    Antibiotic use during pregnancy: a retrospective study of prescription patterns and birth outcomes at an antenatal clinic in rural Ghana

    Babies are increasingly being exposed to antibiotics intrapartum in the bid to reduce neonatal and maternal deaths. Intrapartum antibiotic exposure, including even those considered safe in pregnancy, have been...

    Kwesi Boadu Mensah, Kwame Opoku-Agyeman and Charles Ansah

    Journal of Pharmaceutical Policy and Practice 2017 10:24

    Published on: 9 August 2017

  11. Research

    Drug utilization patterns among elderly hospitalized patients on poly-pharmacy in Punjab, Pakistan

    Reports from drug utilization reviews are important tools employed in the assessment of healthcare practices. The objective of this study was to evaluate drug utilization patterns among elderly hospitalized pa...

    Muhammad Rehan Sarwar, Muhammad Atif, Shane Scahill, Anum Saqib, Muhammad Qamar-uz-Zaman and Zaheer Babar

    Journal of Pharmaceutical Policy and Practice 2017 10:23

    Published on: 4 August 2017

  12. Commentary

    Taking the lead from our colleagues in medical education: the use of images of the in-vivo setting in teaching concepts of pharmaceutical science

    Despite pharmaceutical sciences being a core component of pharmacy curricula, few published studies have focussed on innovative methodologies to teach the content. This commentary identifies imaging techniques...

    Louise E. Curley, Julia Kennedy, Jordan Hinton, Ali Mirjalili and Darren Svirskis

    Journal of Pharmaceutical Policy and Practice 2017 10:22

    Published on: 17 July 2017

  13. Research

    Exploring the status of retail private drug shops in Bangladesh and action points for developing an accredited drug shop model: a facility based cross-sectional study

    The private retail drug shops market in Bangladesh is largely unregulated and unaccountable, giving rise to irrational use of drugs and high Out-of-pocket expenditure on health. These shops are served by sales...

    Syed Masud Ahmed, Nahitun Naher, Tarek Hossain and Lal Bahadur Rawal

    Journal of Pharmaceutical Policy and Practice 2017 10:21

    Published on: 11 July 2017

  14. Review

    The effectiveness of naltrexone combined with current smoking cessation medication to attenuate post smoking cessation weight gain: a literature review

    Smoking is the number one cause of preventable morbidity and mortality globally and although many countries have invested heavily in smoking cessation programs, 21% of the global population still smoke. Post c...

    Raewyn Rees and Ali Seyfoddin

    Journal of Pharmaceutical Policy and Practice 2017 10:20

    Published on: 11 July 2017

  15. Review

    Data exclusivity exceptions and compulsory licensing to promote generic medicines in the European Union: A proposal for greater coherence in European pharmaceutical legislation

    The challenge of providing access to high-priced patented medicines is a global problem affecting all countries. A decade and a half ago the use of flexibilities contained in the World Trade Organization Agree...

    Ellen F. M. ‘t Hoen, Pascale Boulet and Brook K. Baker

    Journal of Pharmaceutical Policy and Practice 2017 10:19

    Published on: 28 June 2017

  16. Research

    Promoting transparency, accountability, and access through a multi-stakeholder initiative: lessons from the medicines transparency alliance

    Barriers to expanding access to medicines include weak pharmaceutical sector governance, lack of transparency and accountability, inadequate attention to social services on the political agenda, and financing ...

    Taryn Vian, Jillian C. Kohler, Gilles Forte and Deirdre Dimancesco

    Journal of Pharmaceutical Policy and Practice 2017 10:18

    Published on: 2 June 2017

  17. Research

    Comparison of medicines management strategies in insurance schemes in middle-income countries: four case studies

    Many middle-income countries are scaling up health insurance schemes to provide financial protection and access to affordable medicines to poor and uninsured populations. Although there is a wealth of evidence...

    Warren A. Kaplan, Paul G. Ashigbie, Mohamad I. Brooks and Veronika J. Wirtz

    Journal of Pharmaceutical Policy and Practice 2017 10:17

    Published on: 16 May 2017

  18. Research

    Individual capacity-building approaches in a global pharmaceutical systems strengthening program: a selected review

    Medicines use related challenges such as inadequate adherence, high levels of antimicrobial resistance and preventable adverse drug reactions have underscored the need to incorporate pharmaceutical services to...

    Niranjan Konduri, Megan Rauscher, Shiou-Chu Judy Wang and Tanya Malpica-Llanos

    Journal of Pharmaceutical Policy and Practice 2017 10:16

    Published on: 8 May 2017

  19. Research

    Two years post affordable medicines facility for malaria program: availability and prices of anti-malarial drugs in central Ghana

    The Affordable Medicines Facility for malaria (AMFm) Program was a subsidy aimed at artemisinin-based combination therapies (ACTs) in order to increase availability, affordability, and market share of ACTs in ...

    Alexander Freeman, Anthony Kwarteng, Lawrence Gyabaa Febir, Seeba Amenga-Etego, Seth Owusu-Agyei and Kwaku Poku Asante

    Journal of Pharmaceutical Policy and Practice 2017 10:15

    Published on: 28 April 2017

  20. Policy Analysis

    Drug pricing and reimbursement decision making systems in Mongolia

    It is essential to allocate available resources equitably in order to ensure accessibility and affordability of essential medicines, especially in less fortunate nations with limited health funding. Currently,...

    Gereltuya Dorj, Bruce Sunderland, Tsetsegmaa Sanjjav, Gantuya Dorj and Byambatsogt Gendenragchaa

    Journal of Pharmaceutical Policy and Practice 2017 10:11

    Published on: 27 February 2017

  21. Commentary

    The changing landscape of expanded access to investigational drugs for patients with unmet medical needs: ethical implications

    When patients are told that standard medical treatment options have been exhausted, their treating physicians may start looking for promising new drugs that are not yet approved, and still under investigation....

    Eline M. Bunnik, Nikkie Aarts and Suzanne van de Vathorst

    Journal of Pharmaceutical Policy and Practice 2017 10:10

    Published on: 21 February 2017

  22. Research

    Capacity for ethical and regulatory review of herbal trials in developing countries: a case study of Moringa oleifera research in HIV-infected patients

    Lack of regulatory capacity limits the conduct of ethical and rigorous trials of herbal medicines in developing countries. Sharing ethical and regulatory experiences of successful herbal trials may accelerate ...

    Tsitsi G. Monera-Penduka, Charles C. Maponga, Gene D. Morse and Charles F. B. Nhachi

    Journal of Pharmaceutical Policy and Practice 2017 10:9

    Published on: 20 February 2017

Previous Page Page 1 of 10 Next Page